Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DIHYDROERGOTAMINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 167 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Micieli, G; Cavallini, A; Marcheselli, S; Mailland, F; Ambrosoli, L; Nappi, G
      Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    2. Bundgaard, H; von Oettingen, G; Jorgensen, HA; Jensen, K; Cold, GE
      Effects of dihydroergotamine on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients undergoing craniotomy for brain tumors

      JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY
    3. Stahl, N; Ungerstedt, U; Nordstrom, CH
      Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries

      INTENSIVE CARE MEDICINE
    4. de Hoon, JNJM; Poppe, KA; Thijssen, HHW; Struijker-Boudier, HAJ; Van Bortel, LMAB
      Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    5. Zakrzewska, JM
      Cluster headache: review of the literature

      BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
    6. Koch, A; Ziegler, S; Breitschwerdt, H; Victor, N
      Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data

      THROMBOSIS RESEARCH
    7. Schoning, C; Flieger, M; Pertz, HH
      Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha(1) receptors in isolated arteries of rat and guinea pig

      JOURNAL OF ANIMAL SCIENCE
    8. Worthington, I
      Delivery systems for acute migraine medications

      CANADIAN FAMILY PHYSICIAN
    9. Centurion, D; Ortiz, MI; Sanchez-Lopez, A; De Vries, P; Saxena, PR; Villalon, CM
      Evidence for 5-HT1B/1D and 5-HT2A receptors mediating constriction of the canine internal carotid circulation

      BRITISH JOURNAL OF PHARMACOLOGY
    10. Critchley, LAH; Woodward, DK
      Haemodynamic effects of three doses of dihydroergotamine during spinal anaesthesia

      BRITISH JOURNAL OF ANAESTHESIA
    11. Kelly, AM
      Migraine: pharmacotherapy in the emergency department

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    12. Damas, F; Hans, P
      Management of the severely head-injured patient within the first 24 hours.Specific therapeutic measures.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    13. Pradalier, A; Baudesson, G; Delage, A
      Acute treatment of the migraine attack.

      PATHOLOGIE BIOLOGIE
    14. Krymchantowski, AV; Barbosa, JS
      Prednisone as initial treatment of analgesic-induced daily headache

      CEPHALALGIA
    15. Silberstein, SD; McCrory, DC
      Opioids

      CEPHALALGIA
    16. Eker, C; Schalen, W; Asgeirsson, B; Grande, PO; Ranstam, J; Nordstrom, CH
      Reduced mortality after severe head injury will increase the demands for rehabilitation sevices

      BRAIN INJURY
    17. Kelly, AM
      Migraine: pharmacotherapy in the emergency department

      WESTERN JOURNAL OF MEDICINE
    18. Lance, JW
      2: Headache and face pain

      MEDICAL JOURNAL OF AUSTRALIA
    19. Lu, SR; Fuh, JL; Juang, KD; Wang, SJ
      Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache

      HEADACHE
    20. McBeath, JG; Nanda, A
      Roller coaster migraine: An underreported injury?

      HEADACHE
    21. Young, WB; Mannix, L; Adelman, JU; Shechter, AL
      Cardiac risk factors and the use of triptans: A survey study

      HEADACHE
    22. Pradalier, A; Lutz, G; Vincent, D
      Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan

      HEADACHE
    23. Redillas, C; Solomon, S
      Prophylactic pharmacological treatment of chronic daily headache

      HEADACHE
    24. Tfelt-Hansen, P; Saxena, PR; Dahlof, C; Pascual, J; Lainez, M; Henry, P; Diener, HC; Schoenen, J; Ferrari, MD; Goadsby, PJ
      Ergotamine in the acute treatment of migraine - A review and European consensus

      BRAIN
    25. Logemann, CD; Rankin, LM
      Newer intranasal migraine medications

      AMERICAN FAMILY PHYSICIAN
    26. Murday, M; McLean, AM; Slaughter, E; Couch, RA
      Determination of dihydroergotamine in human plasma by high-performance liquid chromatography with fluorescence detection

      JOURNAL OF CHROMATOGRAPHY B
    27. Zed, PJ; Loewen, PS; Robinson, G
      Medication-induced headache: Overview and systematic review of therapeuticapproaches

      ANNALS OF PHARMACOTHERAPY
    28. Alexander, P; Giangola, G
      Deep venous thrombosis and pulmonary embolism: Diagnosis, prophylaxis, andtreatment

      ANNALS OF VASCULAR SURGERY
    29. Ducharme, J
      Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache

      JOURNAL OF EMERGENCY MEDICINE
    30. Triner, WR; Bartfield, JM; Birdwell, M; Raccio-Robak, N
      Nitrous oxide for the treatment of acute migraine headache

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    31. Cerbo, R; Pascali, MP; Barbanti, P; Buzzi, MG
      Cluster headache: management of acute attacks before triptans

      ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES
    32. Weitzel, KW; Thomas, ML; Small, RE; Goode, JVR
      Migraine: A comprehensive review of new treatment options

      PHARMACOTHERAPY
    33. Lobo, BL; Cooke, SC; Landy, SH
      Symptomatic pharmacotherapy of migraine

      CLINICAL THERAPEUTICS
    34. van der Kuy, PHM; Lohman, JJHM; Hooymans, PM; Ter Berg, JWM; Merkus, FWHM
      Bioavailability of intranasal formulations of dihydroergotamine

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    35. Bussone, G; Cerbo, R; Martucci, N; Micieli, G; Zanferrari, C; Grazzi, L; Fabbrini, G; Cavallini, A; Granella, F; Ambrosoli, L; Mailland, F; Poli, A; Manzoni, G
      alpha-dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine

      HEADACHE
    36. Young, WB
      Death by managed care - Denial of hospitalization for headache

      HEADACHE
    37. Assie, MB; Cosi, C; Koek, W
      Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Villalon, CM; De Vries, P; Rabelo, G; Centurion, D; Sanchez-Lopez, A; Saxena, P
      Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha(2)-adrenoceptors

      BRITISH JOURNAL OF PHARMACOLOGY
    39. Evers, S; Schmidt, F; Bauer, B; Voss, H; Grotemeyer, KH; Husstedt, IW
      The impact of ergotamine induced headache and ergotamine withdrawal on information processing

      PSYCHOPHARMACOLOGY
    40. WINNER PK
      MIGRAINE - DIAGNOSIS AND RATIONAL TREATMENT

      International journal of fertility and women's medicine
    41. DEWEY RB; RAO SD; HOLMBURG SL; VICTOR RG
      ERGOTAMINE CAFFEINE TREATMENT OF ORTHOSTATIC HYPOTENSION IN PARKINSONISM WITH AUTONOMIC FAILURE/

      European journal of neurology
    42. YOUNG WB; SILBERSTEIN SD; ROZEN TD
      MANAGEMENT OF MIGRAINE - OPPORTUNITY OR BOTTOMLESS PIT

      American journal of managed care
    43. DUCHARME J; BEVERIDGE RC; LEE JS; BEAULIEU S
      EMERGENCY MANAGEMENT OF MIGRAINE - IS THE HEADACHE REALLY OVER

      Academic emergency medicine
    44. WARD TN
      MANAGEMENT OF AN ACUTE PRIMARY HEADACHE

      Clinical neuroscience
    45. BONAVENTURE P; VOORN P; LUYTEN WHML; LEYSEN JE
      5HT(1B) AND 5HT(1D) RECEPTOR MESSENGER-RNA DIFFERENTIAL COLOCALIZATION WITH PEPTIDE MESSENGER-RNA IN THE GUINEA-PIG TRIGEMINAL GANGLION

      NeuroReport
    46. VALENTIN JP; BONNAFOUS R; JOHN GW
      CONTRACTILE RESPONSES EVOKED BY DIHYDROERGOTAMINE, NARATRIPTAN AND SUMATRIPTAN IN THE CANINE ISOLATED CORONARY-ARTERY

      Fundamental and clinical pharmacology
    47. TSUTSUMI K; OBATA Y; TAKAYAMA K; LOFTSSON T; NAGAI T
      EFFECT OF COD-LIVER OIL EXTRACT ON THE BUCCAL PERMEATION OF ERGOTAMINE TARTRATE

      Drug development and industrial pharmacy
    48. DELEU D; HANSSENS F; WORTHING EA
      SYMPTOMATIC AND PROPHYLACTIC TREATMENT OF MIGRAINE - A CRITICAL REAPPRAISAL

      Clinical neuropharmacology
    49. NAREDI S; EDEN E; ZALL S; STEPHENSEN H; RYDENHAG B
      A STANDARDIZED NEUROSURGICAL NEUROINTENSIVE THERAPY DIRECTED TOWARD VASOGENIC EDEMA AFTER SEVERE TRAUMATIC BRAIN INJURY - CLINICAL-RESULTS/

      Intensive care medicine
    50. TFELTHANSEN P
      EFFICACY AND ADVERSE EVENTS OF SUBCUTANEOUS, ORAL, AND INTRANASAL SUMATRIPTAN USED FOR MIGRAINE TREATMENT - A SYSTEMATIC REVIEW BASED ON NUMBER NEEDED TO TREAT

      Cephalalgia
    51. VRAAMARK T; WALDEMAR G; PAULSON OB
      DIFFERENTIAL-EFFECTS OF MIGRAINE DRUGS ON CEREBRAL BLOOD-FLOW AUTOREGULATION

      Cephalalgia
    52. HOLDEN EW; LEVY JD; DEICHMANN MM; GLADSTEIN J
      RECURRENT PEDIATRIC HEADACHES - ASSESSMENT AND INTERVENTION

      Journal of developmental and behavioral pediatrics
    53. CARLETON SC; SHESSER RF; PIETRZAK MP; CHUDNOFSKY CR; STARKMAN S; MORRIS DL; JOHNSON G; RHEE KJ; BARTON CW; CHELLY JE; ROSENBERG J; VANVALEN MK
      DOUBLE-BLIND, MULTICENTER TRIAL TO COMPARE THE EFFICACY OF INTRAMUSCULAR DIHYDROERGOTAMINE PLUS HYDROXYZINE VERSUS INTRAMUSCULAR MEPERIDINEPLUS HYDROXYZINE FOR THE EMERGENCY DEPARTMENT TREATMENT OF ACUTE MIGRAINE HEADACHE

      Annals of emergency medicine
    54. SOMMER S; DELEMAZURE B; WAGNER M; XENARD L; ROZOT P
      BILATERAL ISCHEMIC OPTIC NEUROPATHY DUE T O ERGOTISM

      Journal francais d'ophtalmologie
    55. Wang, YF; Aun, R; Tse, FLS
      Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat

      BIOPHARMACEUTICS & DRUG DISPOSITION
    56. FERRARI MD
      MIGRAINE

      Lancet
    57. MAIZELS M
      THE CLINICIAN APPROACH TO THE MANAGEMENT OF HEADACHE

      Western journal of medicine
    58. EKER C; ASGEIRSSON B; GRANDE PO; SCHALEN W; NORDSTROM CH
      IMPROVED OUTCOME AFTER SEVERE HEAD-INJURY WITH A NEW THERAPY BASED ONPRINCIPLES FOR BRAIN VOLUME REGULATION AND PRESERVED MICROCIRCULATION

      Critical care medicine
    59. GOADSBY PJ
      A TRIPTAN TOO FAR

      Journal of Neurology, Neurosurgery and Psychiatry
    60. NIGHOGHOSSIAN N; DEREX L; TROUILLAS P
      MULTIPLE INTRACEREBRAL HEMORRHAGES AND VASOSPASM FOLLOWING ANTIMIGRAINOUS DRUG-ABUSE

      Headache
    61. FINKEL AG; HOWARD JF; MANN JD
      SUCCESSFUL TREATMENT OF HEADACHE RELATED TO INTRAVENOUS IMMUNOGLOBULIN WITH ANTIMIGRAINE MEDICATIONS

      Headache
    62. Haase, CG; Diener, HC
      Transcranial Doppler ultrasonographic features during drug withdrawal fromdrug-induced headache. A transcranial Doppler follow-up study

      HEADACHE
    63. Drucker, P; Tepper, S
      Daily sumatriptan for detoxification from rebound

      HEADACHE
    64. Treves, TA; Kuritzky, A; Hering, R; Korczyn, AD
      Dihydroergotamine nasal spray in the treatment of acute migraine

      HEADACHE
    65. HAHNE T; BALDA BR
      FINGERTIP NECROSIS AFTER DIHYDROERGOTAMINE MEDICATION IN LIMITED SYSTEMIC SCLERODERMA

      Hautarzt
    66. HOSKIN KL; GOADSBY PJ
      COMPARISON OF MORE AND LESS LIPOPHILIC SEROTONIN (5HT(1B 1D)) AGONISTS IN A MODEL OF TRIGEMINOVASCULAR NOCICEPTION IN CAT/

      Experimental neurology
    67. DEVRIES P; VILLALON CM; HEILIGERS JPC; SAXENA PR
      CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONSTRICTION OF PORCINE CAROTID ARTERIOVENOUS ANASTOMOSES - INVOLVEMENT OF 5HT(1B 1D) AND NOVEL RECEPTORS/

      British Journal of Pharmacology
    68. LESAGE AS; WOUTERS R; VANGOMPEL P; HEYLEN L; VANHOENACKER P; HAEGEMAN G; LUYTEN WHML; LEYSEN JE
      AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES

      British Journal of Pharmacology
    69. GOLD L; BACK T; ARNOLD G; DREIER J; EINHAUPL KM; REUTER U; DIRNAGL U
      CORTICAL SPREADING DEPRESSION-ASSOCIATED HYPEREMIA IN RATS - INVOLVEMENT OF SEROTONIN

      Brain research
    70. ARNDT JO; BOMER W; KRAUTH J; MARQUARDT B
      INCIDENCE AND TIME-COURSE OF CARDIOVASCULAR SIDE-EFFECTS DURING SPINAL-ANESTHESIA AFTER PROPHYLACTIC ADMINISTRATION OF INTRAVENOUS FLUIDS OR VASOCONSTRICTORS

      Anesthesia and analgesia
    71. ROMEIJN SG; MARTTIN E; VERHOEF JC; MERKUS FWHM
      SIMPLIFIED SOLID-PHASE EXTRACTION METHOD FOR DETERMINATION OF DIHYDROERGOTAMINE IN RABBIT AND HUMAN SERUM USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

      Journal of chromatography B. Biomedical sciences and applications
    72. RAPOPORT AM; SHEFTELL FD
      INTRANASAL MEDICATIONS FOR THE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE

      CNS DRUGS
    73. PLATH J; SCHULZE R; BARZ D; KRAMMER B; STEINER M; ANDERS O; MACH J
      NECROTIZING SKIN-LESIONS INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN AFTER TOTAL KNEE ARTHROPLASTY

      Archives of orthopaedic and trauma surgery
    74. ANSARI S; WARWICK D; ACKROYD CE; NEWMAN JH
      INCIDENCE OF FATAL PULMONARY-EMBOLISM AFTER 1,390 KNEE ARTHROPLASTIESWITHOUT ROUTINE PROPHYLACTIC ANTICOAGULATION, EXCEPT IN HIGH-RISK CASES

      The Journal of arthroplasty
    75. BRACCO D; BISSONNETTE B; FAVRE JB; MOESCHLER O; BOULARD G; RAVUSSIN P
      CEREBRAL HEMODYNAMICS AND INTRACRANIAL HY PERTENSIONS

      Annales francaises d'anesthesie et de reanimation
    76. MATHEW NT
      SEROTONIN 1(D) (5-HT1D) AGONISTS AND OTHER AGENTS IN ACUTE MIGRAINE

      Neurologic clinics
    77. GOADSBY PJ; KNIGHT YE
      DIRECT EVIDENCE FOR CENTRAL SITES OF ACTION OF ZOLMITRIPTAN (311C90) - AN AUTORADIOGRAPHIC STUDY IN CAT

      Cephalalgia
    78. MATHEW N
      ZOLMITRIPTAN - FROM DRUG DESIGN TO CLINICAL-PRACTICE - INTRODUCTION

      Cephalalgia
    79. PALMER AJ; SCHRAMM W; KIRCHHOF B; BERGEMANN R
      LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN FOR PREVENTION OF THROMBOEMBOLISM IN GENERAL-SURGERY - A METAANALYSIS OF RANDOMIZEDCLINICAL-TRIALS

      Haemostasis
    80. SWAIN RA; KAPLAN B
      DIAGNOSIS, PROPHYLAXIS, AND TREATMENT OF HEADACHES IN THE ATHLETE

      Southern medical journal
    81. FORD RG; FORD KT
      CONTINUOUS INTRAVENOUS DIHYDROERGOTAMINE IN THE TREATMENT OF INTRACTABLE HEADACHE

      Headache
    82. SAPER JR
      DIAGNOSIS AND SYMPTOMATIC TREATMENT OF MIGRAINE

      Headache
    83. SILBERSTEIN SD
      THE PHARMACOLOGY OF ERGOTAMINE AND DIHYDROERGOTAMINE

      Headache
    84. MATHEW NT
      DOSING AND ADMINISTRATION OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE

      Headache
    85. LIPTON RB
      ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE MESYLATE - SAFETY PROFILES

      Headache
    86. YOUNG WB
      APPROPRIATE USE OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE IN THE TREATMENT OF MIGRAINE - CURRENT PERSPECTIVES

      Headache
    87. EDMEADS JG; GAWEL MJ; VICKERS J
      STRATEGIES FOR DIAGNOSING AND MANAGING MEDICATION-INDUCED HEADACHE

      Canadian family physician
    88. NILSSON F; NILSSON T; EDVINSSON L; BJORKMAN S; NORDSTROM CH
      EFFECTS OF DIHYDROERGOTAMINE AND SUMATRIPTAN ON ISOLATED HUMAN CEREBRAL AND PERIPHERAL ARTERIES AND VEINS

      Acta anaesthesiologica Scandinavica
    89. EZAN E; ARDOUIN T; LANDES BD; FLOUVAT B; HANSLIK T; LEGEAI JM; GROGNET JM
      BIOEQUIVALENCE STUDY OF ALPHA-DIHYDROERGOCRYPTINE - UTILITY OF METABOLITE EVALUATION

      International journal of clinical pharmacology and therapeutics
    90. JONES J; PACK S; CHUN E
      INTRAMUSCULAR PROCHLORPERAZINE VERSUS METOCLOPRAMIDE AS SINGLE-AGENT THERAPY FOR THE TREATMENT OF ACUTE MIGRAINE HEADACHE

      The American journal of emergency medicine
    91. LIMMROTH V; MAY A; DIENER HC
      THE VALUE OF SUMATRIPTAN IN THE ACUTE TRE ATMENT OF MIGRAINE AND CLUSTER HEADACHE

      Nervenheilkunde
    92. NIAZY EM
      DIFFERENCES IN PENETRATION-ENHANCING EFFECT OF AZONE THROUGH EXCISED RABBIT, RAT, HAIRLESS MOUSE, GUINEA-PIG AND HUMAN SKINS

      International journal of pharmaceutics
    93. TSIMOYIANNIS EC; FLORAS G; ANTONIOU N; PAPANIKOLAOU N; TASSIS A
      LOW-MOLECULAR-WEIGHT HEPARINS AND DAFLON FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLISM

      World journal of surgery
    94. EVANS MS; NARITOKU DK; COUCH JR; GHOBRIAL MW
      ONSET OF NEUROLOGIC DEFICITS AFTER TREATMENT WITH DIHYDROERGOTAMINE IN A PATIENT WITH SAGITTAL SINUS THROMBOSIS

      Clinical neuropharmacology
    95. HORBACH T; WOLF H; MICHAELIS HC; WAGNER W; HOFFMANN A; SCHMIDT A; BECK H
      A FIXED-DOSE COMBINATION OF LOW-MOLECULAR-WEIGHT HEPARIN WITH DIHYDROERGOTAMINE VERSUS ADJUSTED-DOSE UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT

      Thrombosis and haemostasis
    96. PIERCE PA; XIE GX; PEROUTKA SJ; LEVINE JD
      DUAL EFFECT OF THE SEROTONIN AGONIST, SUMATRIPTAN, ON PERIPHERAL NEUROGENIC INFLAMMATION

      Regional anesthesia
    97. KALKMAN HO; SCHNEIDER F
      EFFECTS OF ERGOTAMINE AND DIHYDROERGOTAMINE ON 5-HYDROXYTRYPTAMINE-2ARECEPTORS IN THE ISOLATED RAT AORTA

      Pharmacology
    98. GOBEL H; STOLZE H; HEINZE A; DWORSCHAK M; HEUSS D; CHRISTIANI K; LINDNER V
      18-MONTH LONG-TERM ANALYSIS OF THE EFFECT IVENESS, SAFETY AND TOLERABILITY OF SUBCUTANEOUS SUMATRIPTAN IN ACUTE MIGRAINE TREATMENT

      Nervenarzt
    99. CAPOBIANCO DJ; CHESHIRE WP; CAMPBELL JK
      AN OVERVIEW OF THE DIAGNOSIS AND PHARMACOLOGICAL TREATMENT OF MIGRAINE

      Mayo Clinic proceedings
    100. MOUBARAK AS; PIPER EL; JOHNSON ZB; FLIEGER M
      HPLC METHOD FOR DETECTION OF ERGOTAMINE, ERGOSINE, AND ERGINE AFTER INTRAVENOUS-INJECTION OF A SINGLE-DOSE

      Journal of agricultural and food chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 10:12:34